NEW ORLEANS, Sept. 23, 2014 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today a primary focus on assisting plaintiffs of the aftereffects of the pharmaceutical drug Actos. According to court documents on August 28th, U.S. District Judge Rebecca Doherty, the judge who is overseeing thousands of Actos lawsuits, refused to overturn a $9 billion verdict in the first bellwether trial of the proceedings. According to KWQC News in Davenport, IA, the judge ruled against the bid because the jury on the case studied and considered evidence suggesting the officials at Takeda Pharmaceuticals and Eli Lilly knew that the use of Actos could lead to an increased risk in developing bladder cancer but failed to adequately warn both doctors and patients of the possibility. The verdict, which is likely to be reduced on appeal according to legal experts due to its sheer size, is the second-largest in the U.S. in 2014, according to data compiled by Bloomberg. Court documents show the case at hand was the first of over 3,000 Actos lawsuits pending in the Western District of Louisiana to go to trial. All of the pending claims in Louisiana allege that Takeda and other defendants hid the risk of bladder cancer associated with the extended use of the drug.
Chris Janish, CEO of MTS, commented on the recent verdicts, "Unfortunately for Eli Lilly and Takeda, the successful sales with this drug clearly produced a high percentage of bladder cancer victims according to the data and the mass lawsuits. The fact that the judge did not throw the verdict out, in spite of a rare $9Bil jury award, says that the case will now proceed to appeal process and will most likely be reduced due to the excessive nature in the message the jury sent to the Actos drug maker."
MTS advises any patients that have contracted bladder cancer while taking Actos to seek a free legal consultation immediately from an Actos Lawyer or Actos Law firm or by inquiring directly with MTS at: https://www.lawsuitsettlementnews.com/actos-cases
MT Services LLC provides up-to-date lawsuit news on Actos and Bladder Cancer litigations, as well as various services to assist victims with getting the help they need during this difficult time. These services include: Lawsuit Pre-Settlement Funding Cash Advances, corrective or revision surgery procedure funding (or cash needs related to your surgery), and assistance with obtaining an attorney from a nationally recognized Actos law firm. (Lawsuit funding or surgical funding products should not be considered to be a lawsuit loan, lawsuit loans, settlement loans, pre-settlement loans, or lawsuit settlement loans.)
To learn more about the lawsuit help services that MTS can provide involving the Actos litigation visit: https://www.lawsuitsettlementnews.com/about-our-products-and-services
If you or a loved one have been injured by the Actos drug and need lawsuit help, including finding an Actos law firm, obtaining up to $50K in pre-settlement lawsuit funding, or obtaining surgical funding, call right now to speak to a live agent at 877.571.0405. You may also fill out a quick application online at: www.lawsuitsettlementnews.com and an agent will contact you shortly.
MT Services LLC is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer's request. For a list of full disclosures please visit the company's website disclosure page at: https://www.lawsuitsettlementnews.com/terms-of-service
Contact: Chris Janish, CEO
SOURCE MT Services LLC